We report a case of low-molecular-weight heparin (LMWH)-induced skin n
ecrosis in a patient with chronic lymphatic leukemia. The patient had
heparin-PF4 antibodies and the heparin-induced platelet activation (HI
PA) test was positive, but platelet counts remained normal. Analysis o
f seven cases of LMWH-induced skin necrosis revealed that this complic
ation occurred mostly in patients previously exposed to heparin, and t
hat severe problems such as thrombocytopenia or thromboembolic complic
ations were rare. This is in contrast to skin necrosis induced by unfr
actionated heparin (UFH), where a substantially higher number of patie
nts suffered from thrombocytopenia and thromboembolism. In addition, m
ost patients with UFH-induced skin necrosis were not pretreated with h
eparin. Therefore, it is possible that LMWH is less immunogenic than U
FH and requires repeated exposure for induction of skin necrosis.